Proteas head coach Mark Boucher Proteas coach Mark Boucher will wait for a new convenor of selectors before naming his Test captain.Cricket SA is yet to name a replacement for Linda Zondi as selector chief.Faf du Plessis stepped down at Test skipper in February, while Quinton de Kock is the limited overs captain.Proteas coach Mark…
Proteas coach Mark Boucher has stressed the importance of forging ahead with the team's new vision.Cricket South Africa is hard at work finalising dates for both the domestic and international seasons.Boucher says it was vital for the Proteas "to create a new identity" at a recent culture camp.Proteas coach Mark Boucher has emphasised the importance…
Proteas head coach Mark Boucher Figures within cricket have asked questions over the process that led to Proteas head coach Mark Boucher’s speedy appointment in December.Sources told Sport24 that the position was not advertised before being handed to Boucher, days after former Proteas teammate Graeme Smith was named director of cricket.One of the leading voices…
Robert F. Kennedy Jr. has rightly made “radical transparency” the motto of his Department of Health and Human Services. HHS even has a page by that name. I think it is a good motto, and I want to help Secretary Kennedy and Acting FDA Commissioner Kyle Diamantas deliver on it in food safety, with two citizen petitions
Published: October 30, 2026, 10:16 pm Several reports of children choking have led to an FDA warning against Once Upon A Time snacks. The warning covers all flavors, quantities, lots and dates of Once Upon A Farm Tractor Wheels Organic, Toddler Soft-Baked Bars. The FDA has received several reports that describe infants ages 1.5 to
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment